col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

108 Results       Page 1

Elsevier: Journal of Thoracic Oncology
  original article Date Title Authors   All Authors
1 [GO] 2022―Jun―22 Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in Japan Makoto Hibino, Kiyoaki Uryu, Takayuki Takeda, Yusuke Kunimatsu, Shinsuke Shiotsu, Junji Uchino, et al. (+12)
2 [GO] 2022―Apr―21 New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019 Chao Zhang, Yi-Long Wu, Wen-Zhao Zhong
3 [GO] 2022―Feb―17 International Association for the Study of Lung Cancer (IASLC) Study of the Impact of COVID-19 on International Lung Cancer Clinical Trials Matthew P. Smeltzer, Giorgio V. Scagliotti, Heather A. Wakelee, Tetsuya Mitsudomi, Upal Basu Roy, Russell C. Clark, et al. (+10)
4 [GO] 2022―Feb―01 A definitive prognostication system for patients with thoracic malignancies diagnosed with COVID-19: an update from the TERAVOLT registry. Jennifer G. Whisenant, Javier Baena, Alessio Cortellini, Li-Ching Huang, Giuseppe Lo Russo, Luca Porcu, et al. (+65)
5 [GO] 2021―Dec―17 Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment Katsuhiro Masago, Shiro Fujita
6 [GO] 2021―Dec―03 Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An IASLC Early Detection and Screening Committee Report Rudolf M. Huber, Milena Cavic, Anna Kerpel-Fronius, Lucia Viola, John Field, Long Jiang, et al. (+12)
7 [GO] 2021―Nov―16 Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses Valérie Gounant, Valentine Marie Ferré, Ghassen Soussi, Charlotte Charpentier, Héloïse Flament, Nadhira Fidouh, et al. (+9)
8 [GO] 2021―Nov―10 Lung Cancer and SARS-CoV-2 infection: Identifying important knowledge gaps for investigation. Christian Rolfo, Noy Meshulami, Alessandro Russo, Florian Krammer, Adolfo Garcia-Sastre, Philip C. Mack, et al. (+13)
9 [GO] 2021―Oct―26 Do We Really Understand the Relationship Between Expression of ACE2 and Coronavirus Disease 2019 Lung Pathophysiology? Chunxiu Yang, Yueying Li, Shu-Yuan Xiao
10 [GO] 2021―Oct―19 P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19 E. Olson, T. Crilley, H. Rawa, K. Gershner, T. Lycan
11 [GO] 2021―Oct―19 FP13.01 Assessment of the Fear of COVID-19 and Its Impact on Lung Cancer Screening Participation Among the Korean General Population L. Duong, N. Lee, Y. Kim, Y. Kim
12 [GO] 2021―Oct―19 P32.02 2020 in Hindsight: Newly Diagnosed Lung Cancer Patients in the Time of COVID-19 at a Tertiary Canadian Cancer Centre L. Petersen, A. Gibson, K. Gerat, L. Kinch, A. Elegbede, K. Brennan, et al. (+2)
13 [GO] 2021―Oct―19 P34.03 Lung Cancer Patients and COVID-19 in a District General Hospital in the UK A. Aujayeb
14 [GO] 2021―Oct―19 P33.01 Air Leak Due COVID-19 in a Lung Cancer Patient A. Aujayeb
15 [GO] 2021―Oct―19 P32.01 Clinical Screening for COVID-19 in Asymptomatic Patients With Lung Cancer: Brazilian Experience From a Single Institution C.H. Teixeira, C. Yen, T. Teixeira, E. Ferreira, R. Younes, A. Silva, et al. (+3)
16 [GO] 2021―Oct―19 MA12.07 Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center M. Bungaro, V. Bertaglia, M. Audisio, E. Parlagreco, C. Pisano, V. Cetoretta, et al. (+9)
17 [GO] 2021―Oct―19 MA04.07 Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection S. Cedres, J.D. Assaf, P. Iranzo, N. Pardo, A. Martinez-Marti, A. Navarro, et al. (+9)
18 [GO] 2021―Oct―19 P31.06 Impact of Covid-19 Infection on Lung Cancer Patients: Experience in Latin-American Country ACHOCC-19L Study A.V. Ospina Serrano, R. Bruges, W. Mantilla, I. Triana, P. Ramos, S. Aruachan, et al. (+29)
19 [GO] 2021―Oct―19 MA12.02 Factors Associated with Severe COVID-19 Infections in Lung Cancer Patients A.K. Ganti, N. Fillmore, J. La, J. Bihn, M. Kelley
20 [GO] 2021―Oct―19 PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials M. Smeltzer, P.A. Bunn, R. Clark, R. Arndt, C. Pruett, U. Roy, et al. (+4)
21 [GO] 2021―Oct―19 MA05.02 Impact of Covid-19 on Lung Cancer Care and Utilization of Patient Support Resources R. Acharya, A. Ciupek, J. King, L. Fine, M. Goff
22 [GO] 2021―Oct―19 P31.01 Impact of COVID-19 on Lung Cancer Diagnosis and Treatment: A Retrospective Chart Review G. Kasymjanova, A. Anwar, L. Sakr, V. Cohen, D. Small, H. Wang, et al. (+4)
23 [GO] 2021―Oct―19 P31.04 Global Impact of COVID-19 on NSCLC Surgery: Initial Analysis of the CovidSurg-Cancer Study A. Patel, E. Caruana, G. Layton, A. Brunelli, A. Coonar, A. Marchbank, J. Edwards
24 [GO] 2021―Oct―19 OA17.04 The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers M. Smeltzer, B. Bunn, Y.S. Choi, L. Coate, J. Corona-Cruz, A. Drilon, et al. (+24)
25 [GO] 2021―Oct―19 OA01.02 Impact of COVID-19 Outbreak on Lung Cancer Diagnosis and Continuum of Care: Data From an Italian Multicenter Study L. Cantini, G. Mentrasti, S. Siena, G. Pasello, A. Galetti, E. Caliman, et al. (+33)
26 [GO] 2021―Oct―19 P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic M. Mohiuddin, K. Kasahara
27 [GO] 2021―Oct―19 MA12.06 Single Fraction Lung Stereotactic Body Radiotherapy Implementation in a Multi-Center Provincial Cancer Program During the COVID-19 Pandemic B. Mou, D. Hyde, C. Araujo, L. Bartha, A. Bergman, M. Liu
28 [GO] 2021―Oct―19 OA17.03 Depression, Anxiety, and Distress Impact in Patients With Thoracic Malignancies During the COVID-19 Pandemic O. Arrieta, E. Bautista-González, J. Turcott, L. Lara-Mejía, D. Heredia, F. Barrón, et al. (+9)
29 [GO] 2021―Oct―19 OA17.02 COVID-19 Pandemic and Mental Health Status of Lung Cancer Patients in Indonesia H. Afladhia, A. Aji, J. Sunukanto, S. Andarini, J. Zaini, E. Syahruddin
30 [GO] 2021―Oct―19 OA01.03 Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer- a Single-Center Experience L. Hijmering-Kappelle, T.j.n. Hiltermann, F. Bensch
31 [GO] 2021―Oct―19 P31.02 Impact of COVID-19 Pandemic in Spanish and Portuguese Lung Cancer Patients A. Araujo, A. Mendes, R. Pinheiro, V. Calvo, N. Núñez, D. Corbacho, et al. (+12)
32 [GO] 2021―Oct―19 P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain L. Cudero, V. Calvo, Y. Garitaonaindia, A. Collazo-Lorduy, F. Franco, M. Martínez-Cutillas, et al. (+3)
33 [GO] 2021―Oct―19 FP13.03 The Impact of the COVID-19 Pandemic on Lung Cancer Screening Programs in the United States J. King, A. Criswell, R. Mohon, L. Fine
34 [GO] 2021―Oct―19 FP06.02 The Impact of The COVID-19 Pandemic on New Diagnoses of Lung Cancer: A 3-Year Review of an Irish Cancer Centre H. Carroll, M. Doyle, D. Eaton, K. Redmond, B. Mcgovern, D. O'Callaghan, J. Sui
35 [GO] 2021―Oct―19 MA05.03 Considering the Continued Impact of the COVID-19 Pandemic on Patient Advocacy and Support Organisations M. Peters, C. Aldige, W. Boerckel, A. Mcnamara, P. Mondragon, M. Rigney, et al. (+4)
36 [GO] 2021―Oct―19 MA12.05 The Impact of the COVID-19 Pandemic on Post-Operative Outcomes of Thoracic Cancer Surgery in Canada C. Huynh, M. Sorin, D. Jones, A. Simone, E. Delic, A. Fazekas, et al. (+4)
37 [GO] 2021―Oct―19 MA12.03 A Thoracic Cancers International COVID 19 Collaboration Survey on Patients’ Perceptions of COVID-19 (Teravolt-Paper) S. Wong, J. Whisenant, M. Gauthier, M. Garcia, A. Moore, J. King, et al. (+5)
38 [GO] 2021―Oct―19 OA10.04 COVID-19 Vaccine Acceptance and Communications Effectiveness Amongst Canadian Lung Cancer Patients. C. Sit, I. Effiong, M. Bradley, A.M. Cerato, H. Hogan, T. Monds, et al. (+3)
39 [GO] 2021―Oct―19 OA17.01 Core Supportive Care for People Living With Lung Cancer During COVID-19: Analyses of Specialist Lung Cancer Nursing Practice V. Brunelli
40 [GO] 2021―Oct―19 FP06.03 COVID-19: Does Thoracic Surgery Increase Mortality Rates during the Pandemic? M.T. Tsukazan, L. Bittencourt Hinrichsen, G.F. Schneider, P.A. Schulze, M. Iglesias, A. Vigo, et al. (+7)
41 [GO] 2021―Oct―19 MA05.01 Patients’ Experiences During COVID-19: Insights from The Second Global Lung Cancer Coalition Patient Experience Survey J. Fenemore, M. Rigney, W. Boerckel, A. Mcnamara, M. Hennink, J. Mayans, et al. (+6)
42 [GO] 2021―Oct―19 P34.06 Antiproliferative Effects of Paclitaxel on PC9-MET Cells During the Coronavirus Disease 2019 Pandemic M. Mohiuddin, K. Kasahara
43 [GO] 2021―Oct―19 P31.05 SARS-CoV-2 and Lung Cancer: Pandemic Impact in Diagnosis, Staging and Management M.T. Tsukazan, G.F. Schneider, L. Bittencourt Hinrichsen, M. Iglesias, P.A. Schulze, R. Paulino, et al. (+4)
44 [GO] 2021―Oct―19 OA18.03 LUNGCOVID: SARS-CoV-2 Infection in Patients With Thoracic Tumors - Multicenter Observational Study in Portugal D. Magalhães, P. Costa, L. Ferreira, F. Estevinho
45 [GO] 2021―Oct―19 OA01.01 Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls J. Gomez, F. Krammer, P. Mack, C. Rolfo, N. Rohs, A. Moore, et al. (+12)
46 [GO] 2021―Oct―19 MA12.01 A Novel Program Offering Remote, Asynchronous Subspecialist Input in Thoracic Oncology: Early Experience During a Pandemic H. West, Y. Tan, A. Barzi, D. Wong, T. Sachs
47 [GO] 2021―Sep―08 Brief Report Axillary lymphadenopathy after COVID-19 vaccinations in patients with thoracic malignancy: Incidence, predisposing factors, and imaging characteristics Mizuki Nishino, Hiroto Hatabu, Biagio Ricciuti, Victor Vaz, Kesi Michael, Mark M. Awad
48 [GO] 2021―Jul―16 Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology C. Allison Stewart, Carl M. Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson, et al. (+22)
49 [GO] 2021―Jun―22 Brief Report: New Pulmonary Infiltrates Observed on Computed Tomography Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for COVID-19. Graham W. Warren, Vun-Sin Lim, Mudit Chowdhary, Gaurav Marwaha, Osama Mostafa Abd Elbadee, Esra Korkmaz Kirakli, et al. (+6)
50 [GO] 2021―Mar―27 180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19 W. Cui, C. Milner-Watts, S. Saith, J. Bhosle, A.R. Minchom, M. Davidson, et al. (+5)
51 [GO] 2021―Mar―27 35P Lung cancer diagnosis and continuum of care: How did the COVID-19 outbreak impact? Data from an Italian multicenter study L. Cantini, G. Mentrasti, N. La Verde, M.S. Cona, R. Chiari, E. Martinelli, et al. (+12)
52 [GO] 2021―Mar―27 179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center C. Pierre, T. Goter, C. Agar, S. Luzi, H. Lena, Y. Le Guen, C. Ricordel
53 [GO] 2021―Mar―27 205P Impact of UK COVID-19 pandemic cancer guidelines on treatment decisions for thoracic malignancies J. Morton-Gittens, N. Pipalia, K. Thippu Jayaprakash
54 [GO] 2021―Mar―27 43P Incidentally discovered suspicious lung lesions in hospitalized patients during the COVID-19 pandemic in Georgia M. Abuladze, K. Saganelidze, D. Barabadze, M. Kavtaria
55 [GO] 2021―Mar―27 206P Impact of the COVID-19 pandemic in the diagnosis of lung cancer in Portugal M. Leitão, A.R. Teixeira, M.C. Neves, I. Azevedo, C. Vieira
56 [GO] 2021―Mar―27 203MO Changes in management for patients with lung cancer treated with radical radiotherapy during the first wave of the COVID-19 pandemic in the UK (COVID-RT Lung) K. Banfill, G. Price, K. Wicks, A. Britten, C. Carson, M. Hatton, et al. (+11)
57 [GO] 2021―Mar―27 42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis S. Ramella, C.C. Quattrocchi, E. Ippolito, F.M. Giordano, C. Greco, C.A. Mallio, et al. (+5)
58 [GO] 2021―Mar―27 44P Inter-reader variability of lung parenchymal observations on chest CT among COVID-19 RT-PCR negative lung cancer patients treated with chemo-radiation: Potential pitfalls of pulmonary findings in different readers with various experience levels A. Jajodia, H. Prosch, U. Batra, B. Amrith, J. Goyal, S. Pasricha, et al. (+4)
59 [GO] 2021―Mar―20 P09.15 Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19 L. Fernández-Mañas, T. Gorría, E. Auclin, R. Reyes, C. Teixidó, J. Marco-Hernández, et al. (+12)
60 [GO] 2021―Mar―20 P02.14 Radiotherapy-Associated CT Imaging as a Potential Screening Tool for COVID-19 A. Wu, A. Plodkowski, M. Ginsberg, J. Shin, Q. Laplant, A. Shepherd, et al. (+8)
61 [GO] 2021―Mar―20 MA07.08 Needs Assessment of Lung Cancer Patients & Caregivers in the Post-Shelter-in-Place Era in the United States during COVID-19 U. Basu Roy, M. Jacobson, J. Selig
62 [GO] 2021―Mar―20 MA07.09 Lung Cancer Patients Survey Under COVID-19 Epidemic K. Hasegawa
63 [GO] 2021―Mar―20 P09.33 Outcomes of Patients with Lung Cancer Tested for COVID-19 in a Chicago Hospital System (LungCOVID-Chicago) R. Nguyen, K. Fernandez, M. Pasquinelli, L. Liu, L. Feldman
64 [GO] 2021―Mar―20 P88.03 Asymptomatic COVID-19 in a ROS1 positive Non Small Cell Lung Cancer. A. Datta, P. Mohapatra, B. Mishra, S. Mitra, S. Padmaja, M. Panigrahi, et al. (+7)
65 [GO] 2021―Mar―20 P09.35 COVID-19 in Patients with Lung Cancer - Experience from a Thoracic Oncology Center D. Coelho, V. Santos, D. Araújo, H. Novais-Bastos, A. Magalhães, V. Hespanhol, et al. (+2)
66 [GO] 2021―Mar―20 P09.02 Impact of COVID-19 in Portuguese Lung Cancer Patients’ Treatment: Portuguese Lung Cancer Study Group Survey F. Estevinho, A. Figueiredo, F. Barata, A. Barroso, U. Brito, E. Camacho, et al. (+19)
67 [GO] 2021―Mar―20 P09.44 Outcomes of Covid-19 Infection in Lung Cancer Patients: Experience from a Large Tertiary Care Cancer Center K. Munawar, H. Sheikh
68 [GO] 2021―Mar―20 P39.08 The Effect of COVID-19 on Anxiety in Canadian Lung Cancer Patients C. Sit, I. Effiong, A. Redway, A. Pratt, A.M. Cerato, C. Qiong Wu, et al. (+2)
69 [GO] 2021―Mar―20 P09.18 COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT) J. Whisenant, S. Wong, V. Torri, J. Revuelta, B. Halmos, G. Ceresoli, et al. (+20)
70 [GO] 2021―Mar―20 FP06.04 Psychological Distress in Outpatients with Lymphoma, Lung and Breast Cancer during COVID-19 pandemic A. Catino, D. Bafunno, C. Cormio, F. Romito, C. Minoia, G. Loseto, et al. (+13)
71 [GO] 2021―Mar―20 P39.09 Social Media Support of Lung Cancer Patient Associations During the Lockdown Restrictions in Italy: A Breath of Life During the COVID-19 Pandemic. V. Franchina, T. Franchina, G. Ricciardi, V. Adamo
72 [GO] 2021―Mar―20 P09.17 Changes in the Management of Patients Having Radical Radiotherapy in the UK During the COVID-19 Pandemic (COVID-RT Lung) K. Banfill, G. Price, C. Peedell, K. Harland, C. Powell, N. Panakis, et al. (+4)
73 [GO] 2021―Mar―20 MA03.08 Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer R. Reyes, R. López-Castro, E. Auclin, T. García, M.J. Chourio, A. Rodriguez, et al. (+12)
74 [GO] 2021―Mar―20 MA07.07 Assessing the Impact of the COVID-19 Pandemic on Patient Advocacy and Support Organisations M. Peters, M. Rigney, W. Boerckel, C. Aldige, P. Mondragon, J. Fox, et al. (+3)
75 [GO] 2021―Mar―20 MA10.10 Lung Cancer Admission Rates During the COVID-19 Pandemic to a Tertiary Cancer Centre in South East Scotland. F. Torrance, K. Purshouse, P. Hall, M. Mackean, I. Phillips
76 [GO] 2021―Mar―20 P09.28 Access to Intermediate and Intensive Care for Patients With Lung Cancer During the COVID-19 Period T. Gorría, L. Fernández-Mañas, E. Auclin, R. Reyes, R. Lopez Castro, M. García De Herreros, et al. (+15)
77 [GO] 2021―Mar―20 P31.01 A False Alarm of COVID-19 Pneumonia in Lung Cancer: A Case Report of Anti-PD-1 Related Pneumonitis Y. Dai, X. Li, Z. Zhao, S. Liu, Y. Zhang, P. Liu, Y. Zhang
78 [GO] 2021―Mar―20 P09.48 Experience and Outcome of COVID-19-Positive Lung Cancer Patients from a Eastern Indian Hospital P. Mohapatra, S. Bhuniya, M. Panigrahi, S. Bal, S. Goud, S. Padmaja, et al. (+16)
79 [GO] 2021―Mar―20 OA08.04 Providing Thoracic Prehabilitation during COVID-19: Review of a Virtual Model. S. Wynne, F. Dickinson, S. Fraser, N. Peat, P. Labuc, R. Bracegirdle, E. Hawley
80 [GO] 2021―Mar―20 P40.01 Tobacco use in Adolescence and Associated Factors: Products, School, Family, Peers and Movies in Pandemic Period D. Bafunno, A. Catino, V. Lamorgese, D. Galetta, V. Longo, A. Mastrandrea, et al. (+9)
81 [GO] 2021―Jan―14 CP01.03 COVID 19’s Pandemic’s Effect on a Community Lung Cancer Screening Program M. Gieske, G. Kloecker, M. Lockwood, J. Kerns, R. Calhoun
82 [GO] 2021―Jan―10 Coronavirus Infectious Disease Epidemic (COVID-19): where we are, what can be done and hope for. Michele Carbone, John Lednicky, Shu-Yuan Xiao, Mario Venditti, Enrico Bucci
83 [GO] 2020―Nov―25 Histologic Confounding Findings in Coronavirus disease 2019 (COVID-19) Pathology Giulio Rossi, Dora Caruso, Franco Stella, Fabio Davoli
84 [GO] 2020―Oct―24 Immunotherapy and Coronavirus Disease 2019: Challenges and Possibilities Hatoon Bakhribah, Turki Alfayea
85 [GO] 2020―Oct―05 Identification and Resolution of Asymptomatic Coronavirus Disease 2019 Pneumonitis and Colitis: Serial Assessment of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluation of Lung Cancer Biniam Kidane, Daniel P. Levin
86 [GO] 2020―Sep―24 Letter to the Editor Concerning the Article From Cai et al. Focusing on Coronavirus Disease 2019 Impact on Lung Cancer Resection, Published in June 2020 Joseph Seitlinger, Douglas Banga Nkomo, Arthur Streit, Florent Stasiak, Stéphane Renaud
87 [GO] 2020―Aug―29 Two sorts of microthrombi in a COVID-19 patient with lung cancer. Fiorella Calabrese, Francesco Fortarezza, Chiara Giraudo, Federica Pezzuto, Eleonora Faccioli, Federico Rea, et al. (+3)
88 [GO] 2020―May―23 The Management of Patients With Lung Cancer During the Outbreak of Coronavirus Disease 2019 Wen Ouyang, Jing Hu, Hongyan Zhang, Conghua Xie
89 [GO] 2020―May―15 Treatment guidance for lung cancer patients during the COVID-19 pandemic Anne-Marie C. Dingemans, Ross A. Soo, Abdul Rahman Jazieh, Shawn J. Rice, Young Tae Kim, Lynette LS. Teo, et al. (+18)
90 [GO] 2020―May―07 COVID-19 or Lung Cancer: A differential diagnostic experience and management model from Wuhan Jian Zhu, Yu Zhang, Xu-Hui Gao, Er-Ping Xi
91 [GO] 2020―May―05 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)-Associated Interstitial Lung Disease During the COVID-19 Pandemic Hsu-Liang Chang, Yen-Hsu Chen, Chih-Jen Yang
92 [GO] 2020―Apr―29 Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic Sameera Kumar, Steven Chmura, Clifford Robinson, Steven H. Lin, Shirish M. Gadgeel, Jessica Donington, et al. (+5)
93 [GO] 2020―Apr―27 SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy Stefano Cafarotti
94 [GO] 2020―Apr―24 Pulmonary Pathology of Early Phase 2019 Novel Coronavirus Pneumonia Beuy Joob, Viroj Wiwanitkit
95 [GO] 2020―Apr―22 Lessons already learnt from the Covid-19 pandemic José Sanz-Santos, Ramón Rami-Porta, Sergi Call
96 [GO] 2020―Apr―21 A CALL FOR RAPID SUBMISSION OF DATA FOR AGGREGATE REVIEW: Can daily radiotherapy imaging be used as a potential screen for COVID-19? Graham Warren, Alex A. Adjei
97 [GO] 2020―Apr―17 Rapid Detection of Asymptomatic COVID-19 by CT Image-Guidance for Stereotactic Ablative Radiotherapy Gwendolyn J. McGinnis, Matthew S. Ning, Paige L. Nitsch, Michael O’Reilly, Mary Frances McAleer, Albert C. Koong, Joe Y. Chang
98 [GO] 2020―Apr―17 Alert to Potential Contagiousness: A Case of Lung Cancer with Asymptomatic SARS-CoV-2 Infection Wen Ouyang, Jing Yu, Junhong Zhang, Conghua Xie
100 [GO] 2020―Apr―11 COVID-19 in the perioperative period of lung resection: a brief report from a single thoracic surgery department in Wuhan, China Yixin Cai, Zhipeng Hao, Yi Gao, Wei Ping, Qi Wang, Shu Peng, et al. (+9)
101 [GO] 2020―Apr―10 Early appearance of COVID-19 associated pulmonary infiltrates during daily radiotherapy imaging for lung cancer. Morten Hiul Suppli, Steen Riisgaard de Blanck, Tenna Elgaard, Mirjana Josipovic, Mette Pøhl
102 [GO] 2020―Apr―10 COVID-19 or Lung Cancer: what should we treat? Marco Russano, Fabrizio Citarella, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
103 [GO] 2020―Mar―31 A rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in an advanced lung cancer patient with a long time response to nivolumab Lucia Bonomi, Laura Ghilardi, Ermenegildo Arnoldi, Carlo Alberto Tondini, Anna Cecilia Bettini
104 [GO] 2020―Mar―31 18F-FDG uptake in Asymptomatic SARS-CoV-2 (COVID-19) patient, referred to PET/CT for Non-Small Cells Lung Cancer restaging Giulia Polverari, Vincenzo Arena, Francesco Ceci, Ettore Pelosi, Annarita Ianniello, Elana Poli, et al. (+2)
105 [GO] 2020―Mar―17 Exuberant plasmocytosis in bronchoalveolar lavage of the first patient requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe Marco Giani, Davide Seminati, Alberto Lucchini, Giuseppe Foti, Fabio Pagni
106 [GO] 2020―Mar―07 Editorial: Coronaviruses: Facts, Myths and Hypotheses. Michele Carbone, Joshua B. Green, Enrico M. Bucci, John J. Lednicky
107 [GO] 2020―Mar―06 The Treatment and Outcome of a Lung Cancer Patient Infected with SARS-CoV-2 Hongyan Zhang, Yihua Huang, Conghua Xie
108 [GO] 2020―Feb―28 Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer Sufang Tian, Weidong Hu, Li Niu, Huan Liu, Haibo Xu, Shu-Yuan Xiao

108 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec